Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3266621 | 0.76 | MAPT (0.33) | — | |
| SCHEMBL3266375 | 0.76 | — | — | |
| SCHEMBL2198020 | 0.72 | — | — | |
| SCHEMBL3265995 | 0.71 | — | — | |
| SCHEMBL6325480 | 0.70 | PIK3CD (0.38) | MME | |
| SCHEMBL2691336 | 0.67 | — | — | |
| SCHEMBL3266143 | 0.67 | — | — | |
| SCHEMBL2690043 | 0.67 | — | — | |
| SCHEMBL3267353 | 0.67 | MME (0.36) | MME | |
| SCHEMBL7547703 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1517881-B1 | 4-(3,3-DIHALO-ALLYLOXY)PHENOXY ALKYL DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2010-06-02 | — | — | EP | disclosed |
| US-7414064-B2 | 4-(3,3-dihalo-allyloxy) phenoxy alkyl derivatives | SYNGENTA CROP PROTECTION, INC. (US) | 2008-08-19 | — | — | US | disclosed |
| US-20070142445-A1 | 4-(3,3-Dihalo-Allyloxy) Phenoxy Alkyl Derivatives | SYNGENTA CROP PROTECTION, INC. (US) | 2007-06-21 | — | — | US | disclosed |
| US-7192965-B2 | 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives | SYNGENTA CROP PROTECTION, INC. (US) | 2007-03-20 | — | — | US | disclosed |
| US-20050245583-A1 | 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives | SYNGENTA CROP PROTECTION, INC. | 2005-11-03 | — | — | US | disclosed |
| EP-1517881-A1 | 4-(3,3-DIHALO-ALLYLOXY)PHENOXY ALKYL DERIVATIVES | Syngenta Participations AG (CH) | 2005-03-30 | — | — | EP | disclosed |
| WO-2004002943-A1 | 4-(3,3-DIHALO-ALLYLOXY)PHENOXY ALKYL DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2004-01-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050245583-A1 | 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives | DDT, RER1, SCN7A | MME 2072/4885 |
| US-20070142445-A1 | 4-(3,3-Dihalo-Allyloxy) Phenoxy Alkyl Derivatives | DDT, RER1, SCN7A | MME 2072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.